• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?

作者信息

Hillner Bruce E, Smith Thomas J

出版信息

J Clin Oncol. 2007 Feb 20;25(6):611-3. doi: 10.1200/JCO.2006.09.3542.

DOI:10.1200/JCO.2006.09.3542
PMID:17308264
Abstract
摘要

相似文献

1
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?辅助性乳腺癌曲妥珠单抗治疗所带来的巨大益处是否能抵消其高昂成本？
J Clin Oncol. 2007 Feb 20;25(6):611-3. doi: 10.1200/JCO.2006.09.3542.
2
Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab.《临床肿瘤学杂志》中的卫生经济学以及与辅助性曲妥珠单抗相关的间接成本和效益评估
J Clin Oncol. 2007 Aug 1;25(22):3382-3; author reply 3383. doi: 10.1200/JCO.2007.12.3760.
3
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer.曲妥珠单抗在辅助治疗HER2阳性乳腺癌中的成本效益分析。
Cancer. 2007 Aug 1;110(3):489-98. doi: 10.1002/cncr.22806.
4
Trastuzumab in breast cancer.曲妥珠单抗在乳腺癌中的应用
N Engl J Med. 2006 Feb 9;354(6):640-4; author reply 640-4.
5
How much will Herceptin really cost?赫赛汀的实际费用会是多少？
BMJ. 2006 Nov 25;333(7578):1118-20. doi: 10.1136/bmj.39008.624051.BE.
6
Adjuvant trastuzumab for breast cancer: an increasingly common ethical and economic conundrum.乳腺癌辅助性曲妥珠单抗治疗：一个日益常见的伦理和经济难题。
BMJ. 2005 Nov 19;331(7526):1202. doi: 10.1136/bmj.331.7526.1202-b.
7
Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.曲妥珠单抗辅助治疗人表皮生长因子受体2阳性乳腺癌的成本效益
J Clin Oncol. 2007 Feb 20;25(6):625-33. doi: 10.1200/JCO.2006.06.4220.
8
Oh, Canada: Public outcry pushed demand for trastuzumab for early-stage breast cancer.哦，加拿大：公众的强烈抗议推动了早期乳腺癌对曲妥珠单抗的需求。
J Natl Cancer Inst. 2005 Sep 21;97(18):1327. doi: 10.1093/jnci/dji327.
9
[Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer].[曲妥珠单抗辅助治疗HER2阳性早期乳腺癌的成本/效果分析]
Bull Cancer. 2007 Jul;94(7):711-20.
10
Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium.曲妥珠单抗用于早期乳腺癌：比利时的成本效益分析
Health Policy. 2008 Aug;87(2):146-59. doi: 10.1016/j.healthpol.2007.11.003. Epub 2008 Mar 4.

引用本文的文献

1
Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.价格透明度面向谁？寻找自付费用估算以促进癌症护理中的成本沟通。
Pharmacoeconomics. 2018 Mar;36(3):259-261. doi: 10.1007/s40273-018-0613-x.
2
A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.肿瘤学中的成本沟通综述：患者态度、提供者接受度和结果评估。
Cancer. 2017 May 15;123(6):928-939. doi: 10.1002/cncr.30423. Epub 2016 Nov 28.
3
Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
福尔马林固定石蜡包埋乳腺癌组织中HER2 mRNA表达的定量逆转录聚合酶链反应检测
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6752-9. eCollection 2014.
4
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.分析美国与欧洲在癌症治疗方面的医疗保健支出较高是否“物有所值”。
Health Aff (Millwood). 2012 Apr;31(4):667-75. doi: 10.1377/hlthaff.2011.1298.
5
Genomic testing and therapies for breast cancer in clinical practice.临床实践中的乳腺癌基因组检测和治疗。
J Oncol Pract. 2011 May;7(3 Suppl):e1s-7s. doi: 10.1200/JOP.2011.000299.
6
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.回顾曲妥珠单抗治疗的10年：HER2检测的作用是什么？卫生经济分析的系统评价。
Per Med. 2009 Mar;6(2):193-215. doi: 10.2217/17410541.6.2.193.
7
Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics.用小分子转录因子模拟物抑制 ErbB2（Her2）表达。
Bioorg Med Chem Lett. 2009 Nov 1;19(21):6233-6. doi: 10.1016/j.bmcl.2009.08.090. Epub 2009 Sep 1.
8
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.将基因组信息转化为临床实践和卫生政策面临的挑战：利用、偏好和经济价值。
Curr Opin Mol Ther. 2008 Jun;10(3):260-6.
9
Media influence on Herceptin subsidization in Australia: application of the rule of rescue?媒体对澳大利亚赫赛汀补贴的影响：救援原则的应用？
J R Soc Med. 2008 Jun;101(6):305-12. doi: 10.1258/jrsm.2008.070289.